General Info
Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by
Location: 888 Seventh Avenue
Country: United States of America
Industries: Healthcare,Medical Device
Investment Regions: EU, NA
Investment Stages: seed, series-a
Website: http://www.aislingcapital.com/
vc
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Aisling Capital’s news page shows an investment/participation dated May 2, 2024 (BridgeBio/BBOT). From that date to the reference date is more than 12 months (approximately 17 months), so classify as not-active. The invested company found: BridgeBio (BridgeBio Oncology Therapeutics/BBOT).
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Aftab …
Partner
Andrew …
Managing Partner
Dennis …
Founder and Senior Advisor
Eric …
Partner
Josh …
Operating Partner
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Aisling Capital

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
